Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An announcement from Circassia Pharmaceuticals ( (GB:NIOX) ) is now available.
NIOX Group plc, a company listed on the AIM market, has announced a timetable for its proposed final dividend for the financial year ending 31 December 2024. The dividend of 1.25 pence per share is subject to approval at the Annual General Meeting on 14 May 2025, with key dates including an ex-dividend date of 15 May 2025 and a payment date of 16 June 2025.
Spark’s Take on GB:NIOX Stock
According to Spark, TipRanks’ AI Analyst, GB:NIOX is a Neutral.
Circassia Pharmaceuticals shows strong financial performance with robust revenue growth and cash flow management. However, technical analysis suggests a bearish trend, and the high P/E ratio raises valuation concerns. Recent corporate events reflect strategic growth but also highlight uncertainties. Overall, the stock is positioned for growth with caution advised due to valuation and technical indicators.
To see Spark’s full report on GB:NIOX stock, click here.
More about Circassia Pharmaceuticals
YTD Price Performance: -1.59%
Average Trading Volume: 1,245,458
Technical Sentiment Signal: Hold
Current Market Cap: £243.9M
See more data about NIOX stock on TipRanks’ Stock Analysis page.